[go: up one dir, main page]

FI903197A0 - Förfarande för framställning av ett S-proteinhaltigt farmaceutiskt preparat - Google Patents

Förfarande för framställning av ett S-proteinhaltigt farmaceutiskt preparat

Info

Publication number
FI903197A0
FI903197A0 FI903197A FI903197A FI903197A0 FI 903197 A0 FI903197 A0 FI 903197A0 FI 903197 A FI903197 A FI 903197A FI 903197 A FI903197 A FI 903197A FI 903197 A0 FI903197 A0 FI 903197A0
Authority
FI
Finland
Prior art keywords
preparing
pharmaceutical preparation
proteinaceous pharmaceutical
preparation
protein
Prior art date
Application number
FI903197A
Other languages
English (en)
Finnish (fi)
Other versions
FI94927B (sv
FI94927C (sv
Inventor
Hans Peter Schwarz
Ewald Molinari
Yendra Linnau
Susanne Pfeiler
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of FI903197A0 publication Critical patent/FI903197A0/sv
Publication of FI94927B publication Critical patent/FI94927B/sv
Application granted granted Critical
Publication of FI94927C publication Critical patent/FI94927C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI903197A 1989-06-26 1990-06-26 Förfarande för framställning av ett S-proteinhaltigt farmaceutiskt preparat FI94927C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0155189A AT402153B (de) 1989-06-26 1989-06-26 Protein-s-hältige pharmazeutische präparation
AT155189 1989-06-26

Publications (3)

Publication Number Publication Date
FI903197A0 true FI903197A0 (sv) 1990-06-26
FI94927B FI94927B (sv) 1995-08-15
FI94927C FI94927C (sv) 1995-11-27

Family

ID=3515833

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903197A FI94927C (sv) 1989-06-26 1990-06-26 Förfarande för framställning av ett S-proteinhaltigt farmaceutiskt preparat

Country Status (10)

Country Link
US (1) US5143901A (sv)
EP (1) EP0406216B1 (sv)
JP (1) JPH0338528A (sv)
AT (2) AT402153B (sv)
CA (1) CA2019745C (sv)
DE (1) DE59003060D1 (sv)
DK (1) DK0406216T3 (sv)
ES (1) ES2061007T3 (sv)
FI (1) FI94927C (sv)
NO (1) NO902823L (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US6458360B1 (en) 1990-04-25 2002-10-01 The Johns Hopkins University Soluble complement regulatory molecules
WO1993009807A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Methods of inhibiting thrombosis via elevation of circulating endogenous activated protein c levels
DK0658168T3 (da) * 1992-08-27 2001-01-22 Sanquin Bloedvoorziening Antistoffer, som er specifikke for et hæmostatisk protein, anvendelse heraf til isolering af intakt protein, hæmostatiske p
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4418635C2 (de) * 1994-05-27 1997-07-24 Immuno Ag Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen
US7074402B2 (en) * 2000-02-04 2006-07-11 The Scripps Research Institute Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein C (APC)
WO2022002880A1 (en) * 2020-06-29 2022-01-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Anti-protein s single-domain antibodies and polypeptides comprising thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258288A (en) * 1986-07-25 1993-11-02 Genzyme Corporation Vector containing DNA encoding mature human protein S
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
WO1989002747A1 (en) * 1987-10-05 1989-04-06 The American National Red Cross Therapeutic thrombolytic composition

Also Published As

Publication number Publication date
DK0406216T3 (da) 1994-01-17
JPH0338528A (ja) 1991-02-19
AT402153B (de) 1997-02-25
CA2019745A1 (en) 1990-12-26
ES2061007T3 (es) 1994-12-01
CA2019745C (en) 1996-12-31
FI94927B (sv) 1995-08-15
EP0406216A3 (en) 1991-02-06
ATA155189A (de) 1996-07-15
EP0406216A2 (de) 1991-01-02
NO902823D0 (no) 1990-06-25
ATE95818T1 (de) 1993-10-15
US5143901A (en) 1992-09-01
DE59003060D1 (de) 1993-11-18
EP0406216B1 (de) 1993-10-13
FI94927C (sv) 1995-11-27
NO902823L (no) 1990-12-27

Similar Documents

Publication Publication Date Title
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DE69228073D1 (de) Prozess zur darstellung von (5r)-1,1-dimethylethyl-6-cyano-5-oxo-hexanoaten
FI922620A7 (sv) Peptidderivat, förfarande för dess framställning, ett farmaceutisk pre parat innehållande detta och förfarande för behandling av glaukoma
GR3006798T3 (sv)
CA2034489A1 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
DE68912657D1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluorethan.
DE3683586D1 (de) Behandlung des atemunwohlseinsyndroms bei erwachsenen.
DE68908616D1 (de) Verfahren zur Herstellung von 1,1,1-Trifluor-2,2-dichlorethan.
DE59002438D1 (de) L-Carnitin-Magnesium-Zitrat.
FI901949A7 (sv) Syraresistant FGF-blandning och förfarande för behandling av sårbildan de sjukdomar i matsmältningskanalen
FI903197A0 (sv) Förfarande för framställning av ett S-proteinhaltigt farmaceutiskt preparat
DE69004501D1 (de) Materialbehandlungsverfahren.
NO913887L (no) Inklusjonskomplekser med silybinin, fremstilling av disseog farmasoeytiske preparater inneholdende disse
ES535409A0 (es) Procedimiento para pasterizar un plasma de radical-humano
SE9001706D0 (sv) Behaallare jaemte foerfarande foer dess framstaellning
DE69018755D1 (de) Verfahren zur Herstellung von 3-(L-Pyroglutamyl)-L-thiazolidin-4-carbonsäure-Derivaten.
ATE96280T1 (de) Verfahren zur herstellung eines pflanzlichen eiweisshydrolysats und so hergestelltes produkt.
ZA894945B (en) Strontium salt,process for the preparation thereof and pharmaceutical compositions containing it
ATE52894T1 (de) Schwarztrueffelaroma.
KR900007816A (ko) 사이클로프로필-치환된 아졸릴메틸카비놀, 이의 제조방법 및 약제로서의 이의 용도
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
HUT50633A (en) Process for producing pharmaceutical compositions comprising 1,4-dihydropyridine derivatives
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
EP0281089A3 (en) Process for the preparation of factor viii:c deficient plasma, and deficient plasma obtained therwith
IT1239273B (it) Procedimento di preparazione di aromi naturali al tartufo e prodotti ottenuti.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: IMMUNO AKTIENGESELLSCHAFT